Market Tracker

11/27 4:09am ET

Repros Therapeutics Inc (NASDAQ:RPRX)

9.02
Data as of Nov 26
 +0.27 / +3.09%
Today’s Change
5.92
Today|||52-Week Range
22.57
-50.71%
Year-to-Date

Today’s Trading

Previous close8.75
Today’s open8.79
Day’s range8.66 - 9.17
Volume440,222
Average volume (3 months)1,433,379
Market cap$212.4M
Dividend yield--
Data as of 4:00pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)-12.71%
Earnings growth (this year)-4.26%
Earnings growth (next 5 years)-21.91%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...+0.03+0.32%
DRNADicerna Pharmaceutic...+0.36+3.11%
CCXIChemoCentryx Inc+0.03+0.63%
HRTXHeron Therapeutics I...+0.27+3.55%
Data as of 4:00pm ET, 11/26/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$0.00
Annual profit (last year)-$27.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts